NVIDIA Launches Proteina-Complexa for Drug Research

NVIDIA introduced Proteina-Complexa at the GTC 2026 conference to advance generative design for protein binders ^[1]. This tool joins an updated BioNeMo platform designed to streamline healthcare AI workflows ^[1][2]. The release provides researchers with 30 million new protein complex predictions to help identify drug targets ^[1][3]. The expansion focuses on open model families to support physical and healthcare AI development ^[1]. Experts suggest these models represent a significant shift toward agentic AI in scientific fields ^[2]. By offering high-resolution predictions, NVIDIA aims to reduce the time needed for laboratory validation of new treatments ^[1][3].